A previous report described that the expression level of PTHrP, a potent activator of osteoclastic bone resorption, in bone metastases tends to be higher than that in metastases to the kidneys, livers, and lungs using a genome-wide transcriptomics of human SCLC cells in mice [7]. This evidence concerns the gene PTHLH and small cell lung carcinoma.